Insights On Clinical Technologies

  1. 3 Signs Your EDC Is Fit for Today’s Clinical Trials
    4/30/2018

    Provide EDC users the benefits that are essential to successful clinical data management.

  2. To Insource Or Not To Insource: What Is Your Best Clinical Analytics Strategy?
    4/25/2018

    What to consider when making this important strategic decision.

  3. User Acceptance Testing And RTSM System Validation
    4/19/2018

    When implementing a randomization and trial supply management (RTSM) system for a clinical trial, there is a shared responsibility between the RTSM vendor and sponsor organizations to ensure the system performs as intended according to predefined requirements. 

  4. Modern Technologies In Clinical Trials
    4/19/2018

    Trial designs are becoming more complex. Most of these trials are supported by legacy/older technologies that have limited flexibility to quickly adapt to new trial information. The pharmaceutical industry is reaching a tipping point, where the need for flexibility is outweighing the need to be conservative and risk-averse in this highly-regulated environment.

  5. The Recipe For A Perfect eTMF
    4/19/2018

    Six steps to choosing an eTMF for your clinical studies.

  6. CRF Health Supports Agile Sponsor With Site-Based, Phase III Oncology Clinical Trial With eSource Technology Platform
    4/17/2018

    eCOA solution provides a truly patient-centric experience for optimal protocol compliance oncology patients an easy solution to use.

  7. Why User Experience Is Essential to Success with EDC
    4/17/2018

    Busy and diversified sponsor organization required a data management solution flexible enough to meet the unique requirements of each therapeutic area of study.

  8. Understanding The New ICH-GCP Landscape
    4/17/2018

    Can organizations implement today’s regulatory requirements using conventional approaches?

  9. The Stakes Were High In This Phase II Study, But The Risk Was Under Control
    4/17/2018

    Software solutions provider adds value for a midsize pharmaceutical company from a quality, cost and study governance perspective by enabling them to implement risk-based (dynamic) approaches to monitoring.

  10. How And Why To Standardize Medical Coding In Clinical Trials
    4/10/2018

    There are few things more inefficient than a coding specialist manually coding hundreds or thousands of verbatim data entries that have multiple names and spellings for what could have been one standardized term. After searching through all those terms, your specialist then has to code each entry to match the desired term.